Multiple endocrine neoplasia
Also known as MEN, men syndrome, men syndromes, multiple endocrine adenomatosis+2 more
MEN, men syndrome, men syndromes, multiple endocrine adenomatosis, multiple endocrine neoplasia syndrome, multiple endocrine neoplasia syndrome(s).
Recent clinical, regulatory, research and industry developments relating to this disease.
Approval: Sildenafil Actavis (EMA)
Approval: Viagra (EMA)
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q1 2028.
Clinical MilestonesViewHide
- 2026-03-19A Phase II Study of Lenvatinib in Combination With Everolimus in Patients With Advanced Carcinoid TumorsResults expected Q1 2028
- 2026-03-19ClinicalA Phase II Study of Lenvatinib in Combination With Everolimus in Patients With Advanced Carcinoid TumorsResults expected Q1 2028
Clinical trials
The current development programme across all trial phases.
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively.
MEN, men syndrome, men syndromes, multiple endocrine adenomatosis, multiple endocrine neoplasia syndrome, multiple endocrine neoplasia syndrome(s)
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Related entities are derived from literature co-mention (studied together) — associative, not causal.